LabGenomics Co. Ltd (084650) — Cash Flow-to-Debt Ratio
LabGenomics Co. Ltd (084650) has a Cash Flow-to-Debt Ratio of -0.08x as of September 2025, meaning its operating cash flow of ₩-6.41 Billion could theoretically repay 0% of its total liabilities (₩76.00 Billion) in one year. Explore 084650 long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
LabGenomics Co. Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for LabGenomics Co. Ltd across 11 annual periods. Also explore total assets of LabGenomics Co. Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for LabGenomics Co. Ltd (2014–2024)
Year-by-year debt coverage analysis for LabGenomics Co. Ltd. For market capitalisation and broader financial context, see how much is LabGenomics Co. Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.16x | ₩-12.99 Billion | ₩79.35 Billion | ▼ -676.9% |
| 2023 | 0.03x | ₩2.42 Billion | ₩85.31 Billion | ▼ -98.3% |
| 2022 | 1.69x | ₩69.87 Billion | ₩41.32 Billion | ▲ +20.5% |
| 2021 | 1.40x | ₩65.36 Billion | ₩46.57 Billion | ▼ -15.8% |
| 2020 | 1.67x | ₩46.37 Billion | ₩27.82 Billion | ▲ +896.5% |
| 2019 | 0.17x | ₩3.19 Billion | ₩19.06 Billion | ▲ +367.4% |
| 2018 | 0.04x | ₩608.03 Million | ₩16.99 Billion | ▲ +159.3% |
| 2017 | -0.06x | ₩-1.06 Billion | ₩17.52 Billion | ▼ -143.1% |
| 2016 | 0.14x | ₩2.54 Billion | ₩18.17 Billion | ▼ -43.9% |
| 2015 | 0.25x | ₩2.38 Billion | ₩9.54 Billion | ▼ -21.9% |
| 2014 | 0.32x | ₩3.15 Billion | ₩9.86 Billion | — |